Medtronic has recently issued a recall of certain products in the MiniMed insulin pump product line. The Medtronic insulin pump recall began after the U.S. Food and Drug Administration (FDA) found credible proof that the products in question could be vulnerable to a cybersecurity breach.
A Summary of The Medtronic Insulin Pump Recall
According to an announcement by the FDA, the FDA has now become aware that unauthorized individuals could potentially connect wirelessly to a nearby MiniMed insulin pump with cybersecurity vulnerabilities. This means that a person who is not a patient, caregiver, or health care provider could theoretically infiltrate the electronic settings of these insulin pumps.
The FDA has stated that when products affected by the Medtronic insulin pump recall are assaulted digitally, a malicious hacker could deliver an insulin overdose, induce hypoglycemia, disrupt regular insulin injection schedules, or even induce diabetic ketoacidosis. The Medtronic insulin pump recall is actually the second recall to hit Medtronic in the past five years, but the first recall was not related to a cybersecurity threat.
To date, the FDA has not been made aware of any reports related to patient harm or death as a result of a cybersecurity breach, but with the FDA’s announcement, the following products have been marked by the Medtronic insulin pump recall:
- MiniMed™ 508
- MiniMed™ Paradigm™ 511
- MiniMed™ Paradigm™ 512/712
- MiniMed™ Paradigm™ 515/715
- MiniMed™ Paradigm™ 522/722
- MiniMed™ Paradigm™ 522K/722K
- MiniMed™ Paradigm™ 523/723 version 2.4A or lower
- MiniMed™ Paradigm™ 523K/723K version 2.4A or lower
- MiniMed™ Paradigm™ 712E (Only available outside the US)
- MiniMed™ Paradigm™ Veo 554CM/754CM* Version 2.7A or lower (Only available outside the US)
- MiniMed™ Paradigm™ Veo 554/754* Version 2.6A or lower (Only available outside the US)
The FDA made specific note that if they did not provide an accompanying operating system limit that all versions of that product are to be removed under the Medtronic insulin pump recall.
How The Medtronic Insulin Pump Recall Affects Consumers
The FDA has fully committed to the Medtronic insulin pump recall to ensure that Medtronic addresses their cybersecurity issue. In addition to disclosing this information to the public and helping patients replace their affected insulin pump models with newer models, the FDA has promised to keep consumers informed, revealing new information as it becomes available.
In the meantime, if you or a loved one have experienced complications while using products affected by the Medtronic insulin pump recall, legal recourse may be available to you. If you believe that you may have a case to file, be sure to find the proper legal authorities to bring your pleas before the courts: choose Parker Waichman LLP.
At Parker Waichman LLP, experienced trial attorneys are prepared to pursue your claims to their furthest end in the name of earning you the compensation that you deserve. Don’t wait, contact Parker Waichman today for a free consultation and begin your journey for justice.
New York | Brooklyn | Queens | Long Island | New Jersey | Florida
Call us at: 1-800-YOURLAWYER (800-968-7529) | Schedule your free consultation